Phase v0.1 — tiers and first review (Q2 2027)

Published risk-tier rule engine (open-source, versioned).
Credentialed reviewer pool launched, starting with health and high-value finance specialties.
Tier 2 synchronous review for GeraClinic high-value + cross-border actions and GeraCash transactions above configurable thresholds.
Signed review decisions appended to GeraNexus receipt chains.

Open question: reviewer onboarding speed. Training is 80 hours; we need credentialed pool size to grow faster than Tier 2 demand.

Phase v0.5 — breadth and workforce structure (late 2027)

Tier 2 review available across all Gera verticals.
Published reviewer welfare standards, union-friendly engagement.
Dual-review sampling dashboards public.
Appeal process SLA: 48h response, 7d resolution.
Jurisdictional coverage: UK, EU, India, GCC, East Africa.

Open question: unit economics. Tier 2 review cost vs transaction margin is tight on low-value sensitive verticals. Subsidy policy being worked out.

Phase v1.0 — open protocol and regulator interop (2028)

Third-party review providers can onboard to the protocol (not Gera-exclusive).
Reviewer credentials portable across providers.
Regulator integration: published review-rate dashboards accepted as compliance evidence by at least one regulator.
v1.0 spec freeze with 2-year stability commitment.

Open question: regulatory acceptance of the signed- decision format. Early conversations are positive; codification is slow.

What we will not do in v1

AI-only Tier 2 review. Ever.
Sold-priority review lanes for marketplaces.
Reviewer contracts without welfare provisions.

How to follow

Draft spec: gerawitness.com/spec. GitHub issues for debate. Email [email protected] if you work in trust and safety, reviewer welfare, or regulator engagement and want to collaborate.